F. Ann Ed.D. Millner - 15 May 2025 Form 4 Insider Report for MERIT MEDICAL SYSTEMS INC (MMSI)

Reporting relationship: Director
Issuer ticker: MMSI
Reported as of: 15 May 2025
Net transaction value: -$941,375
SEC form: 4
Accepted by SEC: 19 May 2025, 18:51:36 UTC
Prior SEC filing: 18 Nov 2024
Next SEC filing: 19 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Brian G. Lloyd, Attorney-in-Fact

Key filing fact

F. Ann Ed.D. Millner filed Form 4 for MERIT MEDICAL SYSTEMS INC (MMSI) on 19 May 2025.

Key facts

This page summarizes F. Ann Ed.D. Millner's Form 4 filing for MERIT MEDICAL SYSTEMS INC (MMSI).
5 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 19 May 2025, 18:51.

Change

Previous filing in this sequence was filed on 18 Nov 2024.
Current net transaction value: -$941,375.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001649014 Primary reporting owner

Millner F. Ann

Relationship: Director
Address: 1600 WEST MERIT PARKWAY, SOUTH JORDAN
Signature: /s/ Brian G. Lloyd, Attorney-in-Fact
Signature date: 19 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MMSI transaction

Common Stock, No Par Value

Award

Transaction value: $0
Shares: +2,152
Change %: +6.6%
Price: $0.000000
Shares after: 34,543
Date: 15 May 2025
Ownership: Direct
Footnotes: F1

MMSI transaction

Common Stock, No Par Value

Options Exercise

Transaction value: $1,108,612
Shares: +21,250
Change %: +62%
Price: $52.17
Shares after: 55,793
Date: 15 May 2025
Ownership: Direct
Footnotes: F2

MMSI transaction

Common Stock, No Par Value

Sale

Transaction value: $2,049,988
Shares: -21,250
Change %: -38%
Price: $96.47
Shares after: 34,543
Date: 15 May 2025
Ownership: Direct
Footnotes: F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MMSI transaction Derivative

Non-qualified stock options (right to buy)

Options Exercise

Transaction value: $0
Shares: -13,750
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 15 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 13,750
Exercise price: $52.17
Footnotes: F2, F4

MMSI transaction Derivative

Non-qualified stock options (right to buy)

Options Exercise

Transaction value: $0
Shares: -7,500
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 15 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,500
Exercise price: $52.17
Footnotes: F2, F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 5 footnotes

Footnote F1

The reported transaction involved the reporting person's receipt of a grant of 2,152 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 15, 2026. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.

Footnote F2

The acquisition of shares pursuant to an outstanding option and sale of those shares were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan adopted on August 7, 2023.

Footnote F3

The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.16 to $97.16, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Footnote F4

Becomes exercisable in equal annual installments of 33% commencing 05/24/2020.

Footnote F5

Becomes exercisable in equal annual installments of 33% commencing 05/31/2020.